Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Bedrettin, Yildizeli"'
Autor:
Nezih Onur Ermerak, MD, Betul Yilmaz, MD, Saime Batirel, MD, Sehnaz Olgun Yildizeli, MD, Derya Kocakaya, MD, Bulent Mutlu, MD, Serpil Tas, MD, Bedrettin Yildizeli, MD
Publikováno v:
JTCVS Open, Vol 13, Iss , Pp 423-434 (2023)
Objectives: The underlying mechanisms for the development of chronic thromboembolic pulmonary hypertension and prognostic biomarkers are not clear yet. Thus, our aim is to assess and identify new biomarkers for the expression of 84 key genes linked t
Externí odkaz:
https://doaj.org/article/4815c1a8410345fa8a5c0a50e47b01dd
Publikováno v:
JACC: Case Reports, Vol 2, Iss 4, Pp 658-661 (2020)
A 46-year-old man developed chronic thromboembolic pulmonary hypertension and atrial fibrillation after acute pulmonary embolism. He was found incidentally to have an isolated secundum atrial septal defect, as well as a homozygous mutation for the pl
Externí odkaz:
https://doaj.org/article/e4e7ab38bc6f475ea3b8857f227412bc
Autor:
Stefan Guth, Andrea M. D'Armini, Marion Delcroix, Kazuhiko Nakayama, Elie Fadel, Stephen P. Hoole, David P. Jenkins, David G. Kiely, Nick H. Kim, Irene M. Lang, Michael M. Madani, Hiromi Matsubara, Aiko Ogawa, Jaquelina S. Ota-Arakaki, Rozenn Quarck, Roela Sadushi-Kolici, Gérald Simonneau, Christoph B. Wiedenroth, Bedrettin Yildizeli, Eckhard Mayer, Joanna Pepke-Zaba
Publikováno v:
ERJ Open Research, Vol 7, Iss 3 (2021)
Background Pulmonary endarterectomy (PEA), pulmonary arterial hypertension (PAH) therapy and balloon pulmonary angioplasty (BPA) are currently accepted therapies for chronic thromboembolic pulmonary hypertension (CTEPH). This international CTEPH Regi
Externí odkaz:
https://doaj.org/article/18ed9cff6cfb49e7a57d597ad8bdb811
Publikováno v:
International Journal of the Cardiovascular Academy, Vol 5, Iss 4, Pp 152-158 (2019)
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease of pulmonary hypertension (PH) as a consequence obstructive of pulmonary arteries with thromboembolism. Augmented pulmonary vascular resistance and pulmonary a
Externí odkaz:
https://doaj.org/article/4ceed762d4f7498f8b203254b563678f
Autor:
Emine Bozkurtlar, Mehmed Yanartaş, Sehnaz Olgun Yildizeli, Bedrettin Yildizeli, Serpil Taş, Ayşe Zehra Karakoç, Ahmet Zengin, Nezih Onur Ermerak, Bu¨lent Mutlu, Atakan Erkılınç, Hasan Sunar
Publikováno v:
The Annals of Thoracic Surgery. 114:2093-2099
Background Hydatid Cyst is a zoonosis caused by Echinococcus granulosis. Pulmonary artery involvement is a rare condition. The aim of this study was to review our experience in the surgical treatment of pulmonary arterial hydatidosis. Methods Data we
Autor:
Sehnaz Olgun Yildizeli, Halil Atas, G. Nural Bekiroğlu, Ahmet Zengin, Nevsun Inanc, Atakan Erkılınç, Emine Bozkurtlar, Haner Direskeneli, Fatma Alibaz-Oner, Bu¨lent Mutlu, Bedrettin Yildizeli, Mehmed Yanartaş, Cagatay Cimsit, Serpil Taş, Ayşe Zehra Karakoç
Publikováno v:
The Annals of Thoracic Surgery. 114:1253-1261
Background Isolated pulmonary vasculitis (IPV) is a single-organ vasculitis of unknown etiology and may mimic chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to review our clinical experience with pulmonary endarterec
Autor:
Tarık Kıvrak, Burcu Yagmur, Hilal Erken, Derya Kocakaya, Turker Tuncer, Şengül Doğan, Orhan Yaman, Umit Yasar Sinan, Sena Sert Sekerci, Cagri Yayla, Ufuk Iyigun, Mehmet Kis, Ozkan Karaca, Emrah Yesil, Elif Ilkay Yuce Ersoy, Bahar Tekin Tak, Ahmet Oz, Mehmet Kaplan, Zeynep Ulutas, Gamze Yeter Aslan, Nihan Kahya Eren, Fatma Nihan Turhan Caglar, Hatice Solmaz, Ozge Ozden, Hakan Gunes, Umut Kocabas, Mustafa Yenercag, Omer Isık, Cem Yesilkaya, Ali Nail Kaya, Sefa Erdi Omur, Anil Sahin, Erdal In, Nurcan Kırıcı Berber, Cigdem Ileri Dogan, Fatih Poyraz, Emin Erdem Kaya, Ayca Gumusdag, Omer Kumet, Hakki Kaya, Remzi Sarikaya, Seda Turkan Tan, Hidayet Ozan Arabaci, Rengin Cetin Guvenc, Mehtap Yeni, Burcak Kılıckıran Avci, Dilek Cicek Yilmaz, Ahmet Celik, Berkay Ekici, Aycan Fahri Erkan, Veysel Ozgur Baris, Taner Seker, Ferit Böyük, Mehmet Mustafa Can, Hasan Gungor, Hakki Simsek, Bedrettin Yildizeli, Mehmet Ali Kobat, Mehmet Akbulut, Mehdi Zoghi, Omer Kozan
An accurate diagnosis of pulmonary hypertension (PH) is crucial to ensure that patients receive timely treatment. One of the used imaging models to detect pulmonary hypertension is the X-ray. Therefore, a new automated PH-type classification model ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd7e4600e5a86aea7b9577ca1fdc6a04
https://doi.org/10.1101/2023.04.14.23288561
https://doi.org/10.1101/2023.04.14.23288561
Autor:
Nezih Onur Ermerak, Sehnaz Olgun Yildizeli, Derya Kocakaya, Bulent Mutlu, Koray Ak, Serpil Tas, Bedrettin Yildizeli
Background Coronavirus disease 2019 (COVID-19) is still an ongoing entity and every day we face new sequalae of the disease. We hereby present surgical results of patients who are treated for post-COVID chronic thromboembolic pulmonary hypertension.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205483fada200f85484474cb80c15bdf
https://hdl.handle.net/11424/288787
https://hdl.handle.net/11424/288787
Autor:
Halil Atas, Cagatay Cimsit, Dursun Akaslan, Nevsun Inanc, Derya Kocakaya, Bülent Mutlu, Bedrettin Yildizeli, Batur Gonenc Kanar, Sait Karakurt
Publikováno v:
Heart, Lung and Circulation. 31:520-529
BACKGROUND Patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) are often treated with pulmonary arterial hypertension-specific drugs. However, most of these patients remain symptomatic, despite medical treatment. Balloon pu
Autor:
Seda Güleç, Mustafa Aytek Şimşek, Olcay Ozveren, Turgay Isbir, Mehmed Yanartaş, Bedrettin Yildizeli, Bülent Mutlu, M. Muzaffer Değertekin, Serpil Taş, Ayça Türer Cabbar, Sehnaz Olgun Yildizeli
Publikováno v:
Heart, Lung and Circulation. 31:110-118
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary embolism, and pulmonary endarterectomy (PEA) is the surgical treatment. Asymmetric dimethylarginine (ADMA) levels are increased in pulmonary hypertension. This st